The exposure of healthy subjects to high altitude represents a model to explore the pathophysiology of diseases related to tissue hypoxia and to evaluate pharmacological approaches potentially useful as a therapy for chronic diseases related to hypoxia. We explored the urinary peptidome to detect alterations induced by the exposure of subjects to different altitudes (sea level, high altitude = 3500 m, very high altitude = 5400 m) and to pharmacological treatment. Urine samples were collected from 47 subjects, randomly and blindly assigned to placebo (n = 24) or Telmisartan (n = 23). Samples were purified by the use of magnetic beads, then analysed by MALDI-TOF MS. Results showed that the urinary peptidome is not affected by the administration of Telmisartan, neither at the sea level nor at high and very high altitudes. In contrast, the urinary protein profiles are modified when subjects are exposed to high and very high altitudes, and we detected six peptides differentially expressed in hypobaric hypoxia at high or very high altitude compared to the sea level. Two of them were identified as fragments of the glycoprotein uromodulin and of the a1-antitrypsin. This is the first proteomic study showing that hypobaric hypoxia conditions affect the urinary peptidome.

Mainini, V., Gianazza, E., Chinello, C., Bilo, G., Revera, M., Giuliano, A., et al. (2012). Modulation of urinary peptidome in humans exposed to high altitude hypoxia. MOLECULAR BIOSYSTEMS, 8, 959-966 [10.1039/c1mb05377a].

Modulation of urinary peptidome in humans exposed to high altitude hypoxia

MAININI, VERONICA;GIANAZZA, ERICA;CHINELLO, CLIZIA;BILO, GRZEGORZ;REVERA, MIRIAM;GIULIANO, ANDREA;CALDARA, GIANLUCA;LOMBARDI, CAROLINA;PIPERNO, ALBERTO;MAGNI, FULVIO;PARATI, GIANFRANCO
2012

Abstract

The exposure of healthy subjects to high altitude represents a model to explore the pathophysiology of diseases related to tissue hypoxia and to evaluate pharmacological approaches potentially useful as a therapy for chronic diseases related to hypoxia. We explored the urinary peptidome to detect alterations induced by the exposure of subjects to different altitudes (sea level, high altitude = 3500 m, very high altitude = 5400 m) and to pharmacological treatment. Urine samples were collected from 47 subjects, randomly and blindly assigned to placebo (n = 24) or Telmisartan (n = 23). Samples were purified by the use of magnetic beads, then analysed by MALDI-TOF MS. Results showed that the urinary peptidome is not affected by the administration of Telmisartan, neither at the sea level nor at high and very high altitudes. In contrast, the urinary protein profiles are modified when subjects are exposed to high and very high altitudes, and we detected six peptides differentially expressed in hypobaric hypoxia at high or very high altitude compared to the sea level. Two of them were identified as fragments of the glycoprotein uromodulin and of the a1-antitrypsin. This is the first proteomic study showing that hypobaric hypoxia conditions affect the urinary peptidome.
Articolo in rivista - Articolo scientifico
urinary peptidome, hypoxia, high altitude
fluidi biologici, proteomica, marcatori, clinprot, biglie magnetiche
English
2012
8
959
966
reserved
Mainini, V., Gianazza, E., Chinello, C., Bilo, G., Revera, M., Giuliano, A., et al. (2012). Modulation of urinary peptidome in humans exposed to high altitude hypoxia. MOLECULAR BIOSYSTEMS, 8, 959-966 [10.1039/c1mb05377a].
File in questo prodotto:
File Dimensione Formato  
Modulation of urinary-Molecular BioSystems 2012.pdf

Solo gestori archivio

Dimensione 1.21 MB
Formato Adobe PDF
1.21 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/32133
Citazioni
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
Social impact